Changes to the National Immunisation Schedule
PHARMAC is pleased to announce further decisions related to the National Immunisation Schedule (NIS) that will take effect from 1 July 2014.
Decision to award sole supply to Tacrolimus Sandoz
PHARMAC has decided to award Tacrolimus Sandoz capsules Sole Subsidised Supply status in the community, and Hospital Supply Status in DHB hospitals.
February 2014 tender notification
PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the Invitation to Tender, dated 07 November 2013.
RFP - Supply of erythropoietin
PHARMAC invites proposals for the supply of erythropoietin in New Zealand. Closes: 1 April 2014.
Agreement with Smith & Nephew Limited for the Supply of Wound Care Products
PHARMAC is pleased to announce the approval of an agreement with Smith & Nephew Limited (“Smith & Nephew”) for the supply of wound care products.
PHARMAC seeking public views on proposed new decision criteria
PHARMAC is asking for people’s views on a proposed new framework for making pharmaceutical funding decisions.
Proposal to list a range of Wound Care products supplied by 3M New Zealand Limited
PHARMAC is seeking feedback on a proposal to list a range of wound care products supplied by 3M New Zealand Limited (“3M”) in Part III of Section H of the Pharmaceutical Schedule from 1 April 2014. Closes: Wednesday, 12 March 2014.
Widening of funding restrictions for rituximab and eltrombopag
PHARMAC is pleased to announce the approval of proposals to widen the restriction on rituximab use in DHB hospitals and expand the funding of eltrombopag in both hospitals and the community.
Decision criteria consultation – proposal for change
PHARMAC is seeking feedback on the criteria it uses to make decisions. You can have your say on our proposed changes to the decision criteria. Closes: 5 pm, Monday, 21 April 2014.
Applications sought for Consumer Advisory Committee
PHARMAC is seeking three new people for its Consumer Advisory Committee.
RFP - Supply of national vaccine purchasing, storage and distribution services
PHARMAC invites proposals for the supply of national vaccine purchasing, storage and distribution services to PHARMAC.
Proposal for paliperidone depot injection, risperidone depot injection and olanzapine depot injection
PHARMAC is seeking feedback on a proposal to fund paliperidone depot injection (Invega Sustenna) from 1 May 2014 in conjunction with a price decrease on risperidone depot injection (Risperdal Consta), both through a provisional agreement with Janssen-Cilag Pty Ltd (Janssen). Closes 5 pm, Friday, 28 February 2014.
Proposal for sole supply of nicotine replacement therapy (NRT)
PHARMAC is seeking feedback on a proposal to enter into a new sole supply arrangement with Novartis Consumer for Habitrol, the currently funded brand of nicotine lozenges, patches and gum (nicotine replacement therapy; NRT). Closes 5 pm, Friday, 28 February 2014.
PHARMAC tender reveals vibrant market for pharmaceuticals
The number of companies bidding to be suppliers through the PHARMAC tender has grown to its largest size ever.
Progressing to a request for proposals for the supply and distribution of compression hosiery for the treatment of venous leg ulcers
PHARMAC would like to notify suppliers, DHBs, service providers and treating clinicians that PHARMAC’s interest in this area is now expected to be progressed further via a request for proposals (RFP) for the supply and distribution of compression hosiery for the treatment of venous leg ulcers (VLU).
January 2014 tender notification
PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2012/13 Invitation to Tender, dated 31 October 2012.
Captopril tablets discontinued – transition advice to another ACE inhibitor
A recall has been issued for stock of the currently funded captopril tablets, 12.5 mg, 25 mg, and 50 mg m-Captopril tablets. PHARMAC has been unable to secure a continued, long-term supply of captopril tablets so captopril tablets will no longer be funded via the Pharmaceutical Schedule. We recommend that prescribers transition their patients to another funded alternative.
Proposal for sole supply of tacrolimus
PHARMAC is seeking feedback on a proposal to list Tacrolimus Sandoz in the Pharmaceutical Schedule, and to award Sole Subsidised Supply Status (the only funded brand in the community) and Hospital Supply Status (the only available brand in DHB hospitals, subject to a 1% discretionary variance limit) to Tacrolimus Sandoz. Closes: Friday, 14 February 2014.
Request for information on the potential listing of a range of medicines
PHARMAC is interested in receiving information from suppliers and other interested parties relating to the supply of a range of medicines that are not currently registered with Medsafe in New Zealand. Closes: 5 pm, Friday, 7 March 2014.
Approval of agreement for Applied Medical New Zealand Limited supply of disposable laparoscopic medical devices
PHARMAC is pleased to announce the approval of an agreement with Applied Medical New Zealand Ltd (Applied Medical) for the supply of a selection of disposable laparoscopic devices.
Newsletters
Device Advice: Your update on PHARMAC’s Hospital Medical Devices programme.
Media queries
Media phone is monitored 9am–5pm weekdays
